Assessing the impact of brachytherapy boost in intermediate-risk, early-stage cervical cancer treatment

被引：0
|
作者：
Agusti, Nuria [1 ]
Viveros-Carreno, David [2 ]
Melamed, Alexander [3 ]
Pareja, Rene [2 ]
Wu, Chi-Fang [1 ]
Kanbergs, Alexa [1 ]
Rauh-Hain, Jose [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Inst Nacl Cancerol, Bogota, Colombia
[3] Columbia Univ, Vagelos Coll Phys & Surg, Boston, MA USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2266
引用
收藏
页码：S375 / S376
页数：2
相关论文
共 50 条
  • [1] PREDICTORS OF RECURRENCE IN SURGICALLY STAGED INTERMEDIATE-RISK EARLY-STAGE CERVICAL CANCER
    Artuso, Valeria
    Meschini, Tommaso
    Schivardi, Gabriella
    Antonio De Vitis, Luigi
    Multinu, Francesco
    Martin-Calvo, Nerea
    Chiva, Luis
    Ghezzi, Fabio
    Casarin, Jvan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A87 - A88
  • [2] Adenocarcinoma as an independent risk factor for early-stage intermediate-risk cervical carcinoma
    Mathews, C.
    Goodrich, S.
    Farrell, R.
    DeSimone, C.
    Seamon, L.
    Landrum, L.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S104 - S105
  • [3] Management of patients with intermediate-risk early stage cervical cancer
    Cibula, David
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (03)
  • [4] Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer
    Matsuo, Koji
    Shimada, Muneaki
    Matsuzaki, Shinya
    Machida, Hiroko
    Shigeta, Shogo
    Yoshida, Hiroshi
    Kato, Kazuyoshi
    Kanao, Hiroyuki
    Takekuma, Munetaka
    Mikami, Mikio
    Okamoto, Aiko
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (09) : 1349 - 1358
  • [5] A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors
    Fu, Chunli
    Wang, Cong
    Qian, Qiuhong
    Zhang, Youzhong
    Ma, Changdong
    Miao, Li
    Zhang, Guangyu
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 48
  • [6] Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer
    Cao, Lijie
    Wen, Hao
    Feng, Zheng
    Han, Xiaotian
    Zhu, Jun
    Wu, Xiaohua
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 52 - 58
  • [7] A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors.
    Zhang, Guangyu
    Fu, Chunli
    Ma, Changdong
    Zhang, Youzhong
    Miao, Li
    Wang, Cong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17521 - E17521
  • [8] Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer
    Chatterjee, Sudeshna
    Chen, Ling
    Tergas, Ana I.
    Burke, William M.
    Hou, June Y.
    Hu, Jim C.
    Ananth, Cande V.
    Neugut, Alfred I.
    Hershman, Dawn L.
    Wright, Jason D.
    OBSTETRICS AND GYNECOLOGY, 2016, 127 (06): : 992 - 1002
  • [9] Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
    Kim, Se Ik
    Kim, Tae Hun
    Lee, Maria
    Kim, Hee Seung
    Chung, Hyun Hoon
    Lee, Taek Sang
    Jeon, Hye Won
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong Sang
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 11
  • [10] Impact of adjuvant radiotherapy on survival outcomes in intermediate-risk, early-stage cervical cancer: analyses regarding surgical approach of radical hysterectomy
    Kim, Se Ik
    Kim, Tae Hun
    Lee, Maria
    Kim, Jae-Weon
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S174 - S175
12345